Table 2.

Measures of liver fibrosis by analysis sample.

	APRI/FIB-4 Sample n=106	VCTE Sample n=63
FIB-4		n=61
Median (25th, 75th)	1.35 (0.99, 1.89)	1.38 (0.99, 1.87)
Min, Max	0.44, 5.96	0.44, 5.96
APRI		n=61
Median (25th, 75th)	0.34 (0.26, 0.56)	0.33 (0.26, 0.56)
Min, Max	0.10, 3.98	0.10, 3.98
VCTE (kPa)	n=61
Median (25th, 75th)	4.9 (3.8, 6.6)	4.9 (3.8, 6.8)
Min, Max	2.7, 29.7	2.7, 29.7
Histological Activity Index
Median (25th, 75th)	3 (2, 4)	3 (2, 4)
Min, Max	0, 14	0, 14
Fibrosis Ishak score
0	28 (26.4%)	18 (28.6%)
1	39 (36.8%)	26 (41.3%)
2	15 (14.2%)	6 (9.5%)
3	16 (15.1%)	8 (12.7%)
4	4 (3.8%)	2 (3.2%)
5	1 (0.9%)	1 (1.6%)
6	3 (2.8%)	2 (3.2%)
Advanced Fibrosis (F ≥ 3)	24 (22.6%)	13 (20.6%)

Abbreviations: APRI, aspartate aminotransferase to platelet ratio index; Fibrosis Ishak score, F; FIB-4, fibrosis index based on four factors; VCTE, vibration controlled transient elastography; kPa, kiloPascals